FASN and metabolic dysfunction-associated steatotic liver disease: Previous studies showed that SREBP‐1c57 and SCD‐158 levels were up‐regulated in the fatty livers of NAFLD patients, and higher FASN levels were confirmed in human liver samples and the murine model of hepatic steatosis.59